Gelb Lawrence D
Washington University School of Medicine, St Louis, MO 63110, USA.
Herpes. 2009 Jan;15(3):62-3.
In May 2008, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention in the USA recommended the routine administration of a live-attenuated high-potency varicella zoster vaccine to all adults over 60 years of age without specific contraindications, for the prevention and attenuation of herpes zoster (HZ). Nevertheless, many physicians still consider this vaccine to be of marginal value. This is not a reasonable conclusion. This short article reviews available data.
2008年5月，美国疾病控制与预防中心的免疫实践咨询委员会（ACIP）建议，对所有60岁以上无特定禁忌证的成年人常规接种高效减毒水痘带状疱疹疫苗，以预防和减轻带状疱疹（HZ）。然而，许多医生仍认为这种疫苗价值不大。这并非合理结论。本文综述现有数据。
